Submitted by Anonymous (not verified) on 1 August 2025 - 11:40
Human medicines European public assessment report (EPAR): Vyloy, zolbetuximab, Date of authorisation: 19/09/2024, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Vyloy, zolbetuximab, Date of authorisation: 19/09/2024, Revision: 3, Status: Authorised